Medicamen Biotech Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 326.41 million compared to INR 329.22 million a year ago. Revenue was INR 334.68 million compared to INR 329.23 million a year ago. Net income was INR 37.79 million compared to INR 30.15 million a year ago. Basic earnings per share from continuing operations was INR 3.09 compared to INR 2.47 a year ago. Diluted earnings per share from continuing operations was INR 3.09 compared to INR 2.47 a year ago.
For the nine months, sales was INR 926.91 million compared to INR 914.77 million a year ago. Revenue was INR 940.74 million compared to INR 916.94 million a year ago. Net income was INR 121.52 million compared to INR 84.83 million a year ago. Basic earnings per share from continuing operations was INR 9.95 compared to INR 6.94 a year ago. Diluted earnings per share from continuing operations was INR 9.95 compared to INR 6.94 a year ago.